Market Overview

Vascular Biogenics (NASDAQ: VBLT)

1.18 +0.01 (0.85%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/27/19OppenheimerInitiates Coverage OnOutperform2.0
10/15/18H.C. WainwrightUpgradesBuy3.0
3/09/18Chardan CapitalDowngradesNeutral
3/08/18H.C. WainwrightDowngradesNeutral
3/28/17H.C. WainwrightReiteratesBuy11.0
6/28/16H.C. WainwrightInitiates Coverage onBuy11.0
3/09/16JMP SecuritiesMaintainsMarket Outperform8.0
11/09/15PiperJaffrayInitiates Coverage onOverweight
9/21/15Chardan CapitalInitiates Coverage onBuy25.0
5/22/15Roth CapitalInitiates Coverage onBuy13.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter